Core Scientific shares increased by 6%, CoreWeave merger rejected.

CoreWeave's offer to acquire Core Scientific was rejected following the voting process. This situation marks the end of Core Scientific's initiative aimed at reducing leasing costs and expanding artificial intelligence data center capacity.

Core Scientific investors, including groups such as Two Seas Capital, argued that the stock offer did not provide downside protection and failed to adequately assess future growth. After the vote, CoreWeave's stock experienced a decline of approximately 5%, while Core Scientific's shares gained about 6%. Investors are showing support for Core Scientific's independent growth path.